BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29157234)

  • 1. Zinc transporters and insulin resistance: therapeutic implications for type 2 diabetes and metabolic disease.
    Norouzi S; Adulcikas J; Sohal SS; Myers S
    J Biomed Sci; 2017 Nov; 24(1):87. PubMed ID: 29157234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc transporters and zinc signaling: new insights into their role in type 2 diabetes.
    Myers SA
    Int J Endocrinol; 2015; 2015():167503. PubMed ID: 25983752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc transporters, mechanisms of action and therapeutic utility: implications for type 2 diabetes mellitus.
    Myers SA; Nield A; Myers M
    J Nutr Metab; 2012; 2012():173712. PubMed ID: 23304467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Zinc Transporter ZIP7 in the Treatment of Insulin Resistance and Type 2 Diabetes.
    Adulcikas J; Sonda S; Norouzi S; Sohal SS; Myers S
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc stimulates glucose oxidation and glycemic control by modulating the insulin signaling pathway in human and mouse skeletal muscle cell lines.
    Norouzi S; Adulcikas J; Sohal SS; Myers S
    PLoS One; 2018; 13(1):e0191727. PubMed ID: 29373583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc's role in the glycemic control of patients with type 2 diabetes: a systematic review.
    de Carvalho GB; Brandão-Lima PN; Maia CS; Barbosa KB; Pires LV
    Biometals; 2017 Apr; 30(2):151-162. PubMed ID: 28138861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets.
    Chen B; Yu P; Chan WN; Xie F; Zhang Y; Liang L; Leung KT; Lo KW; Yu J; Tse GMK; Kang W; To KF
    Signal Transduct Target Ther; 2024 Jan; 9(1):6. PubMed ID: 38169461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Zinc Homeostasis in the Pathogenesis of Diabetes and Obesity.
    Fukunaka A; Fujitani Y
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired insulin clearance as a cause rather than a consequence of insulin resistance.
    Watada H; Tamura Y
    J Diabetes Investig; 2017 Nov; 8(6):723-725. PubMed ID: 28752566
    [No Abstract]   [Full Text] [Related]  

  • 11. Zinc transporter gene expression and glycemic control in post-menopausal women with Type 2 diabetes mellitus.
    Foster M; Chu A; Petocz P; Samman S
    J Trace Elem Med Biol; 2014 Oct; 28(4):448-52. PubMed ID: 25156968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Zinc Homeostasis in the Prevention of Diabetes Mellitus and Cardiovascular Diseases.
    Tamura Y
    J Atheroscler Thromb; 2021 Nov; 28(11):1109-1122. PubMed ID: 34148917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc and its transporters, pancreatic β-cells, and insulin metabolism.
    Huang L
    Vitam Horm; 2014; 95():365-90. PubMed ID: 24559925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Zinc Transporter Zip7 Is Downregulated in Skeletal Muscle of Insulin-Resistant Cells and in Mice Fed a High-Fat Diet.
    Norouzi S; Adulcikas J; Henstridge DC; Sonda S; Sohal SS; Myers S
    Cells; 2019 Jul; 8(7):. PubMed ID: 31266232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-Sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic Homeostasis.
    Wu HK; Zhang Y; Cao CM; Hu X; Fang M; Yao Y; Jin L; Chen G; Jiang P; Zhang S; Song R; Peng W; Liu F; Guo J; Tang L; He Y; Shan D; Huang J; Zhou Z; Wang DW; Lv F; Xiao RP
    Circulation; 2019 Feb; 139(7):901-914. PubMed ID: 30586741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Zinc and type 2 diabetes].
    Fukunaka A; Fujitani Y
    Nihon Rinsho; 2016 Jul; 74(7):1132-7. PubMed ID: 27455802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of reduced insulin-stimulated bone blood flow in the pathogenesis of metabolic insulin resistance and diabetic bone fragility.
    Hinton PS
    Med Hypotheses; 2016 Aug; 93():81-6. PubMed ID: 27372862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of purinergic signaling on glucose transporters: A possible mechanism against insulin resistance?
    Teixeira GP; Faria RX
    Eur J Pharmacol; 2021 Feb; 892():173743. PubMed ID: 33220279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of impaired zinc homeostasis in diabetic cardiomyopathy and nephropathy.
    Giacconi R; Cai L; Costarelli L; Cardelli M; Malavolta M; Piacenza F; Provinciali M
    Biofactors; 2017 Nov; 43(6):770-784. PubMed ID: 28845600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular pH Regulation of Skeletal Muscle in the Milieu of Insulin Signaling.
    Posa DK; Baba SP
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32977552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.